-+ 0.00%
-+ 0.00%
-+ 0.00%

MAIA BIOTECHNOLOGY ACHIEVES PATIENT ENROLLMENT MILESTONES IN ONGOING PHASE 2 AND PIVOTAL PHASE 3 CLINICAL TRIALS IN NON-SMALL CELL LUNG CANCER

Reuters·10/07/2026 12:15:00

Please log in to view news